INDUSTRY — LIFE SCIENCES
Life Sciences AI
Pharma and biotech operate in the same regulatory neighborhood as our 15-year healthcare IT practice. GxP, 21 CFR Part 11, and FDA AI guidance aren't new territory for us.

THE CONTEXT
Regulated AI in life sciences
In life sciences, every AI system touches a validation requirement. From GxP-qualified infrastructure to FDA submission documentation, the compliance architecture isn't a layer you add later — it's the foundation you design from. Our work in adjacent regulated environments means we build that way by default.
Electronic records and signatures — the foundation of GxP compliance for AI
Evolving FDA framework for AI/ML in drug development and medical devices
Process validation requirements for AI in GMP/GCP/GLP environments
European Medical Device and In Vitro Diagnostic regulations for AI-enabled devices
VALIDATED AI
Where AI creates value in life sciences
FIRST CONVERSATION